Skip to main content
. Author manuscript; available in PMC: 2018 Oct 17.
Published in final edited form as: Acc Chem Res. 2017 Sep 28;50(10):2577–2588. doi: 10.1021/acs.accounts.7b00347

Figure 4.

Figure 4

Immunofluorescence imaging of γH2AX and 53BP1 foci in K562 cells treated with (–)-lomaiviticin A (4), (–)-lomaiviticin C (6), or (–)-kinamycin C (2). See refs 16 and 22 for conditions.